242 related articles for article (PubMed ID: 22490464)
21. Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma.
Nakamura Y; Nakamura Y; Hori E; Furuta J; Ishii Y; Takahashi T; Kawachi Y; Otsuka F
Int J Dermatol; 2009 Jul; 48(7):763-7. PubMed ID: 19570088
[TBL] [Abstract][Full Text] [Related]
22. Tumor lysis syndrome.
Arrambide K; Toto RD
Semin Nephrol; 1993 May; 13(3):273-80. PubMed ID: 8321927
[TBL] [Abstract][Full Text] [Related]
23. Treatment of tumor lysis syndrome with the highest known uric acid level.
Ozkan G; Ulusoy S; Sönmez M; Kaynar K; Karagülle M
Ren Fail; 2010; 32(7):895-8. PubMed ID: 20662707
[TBL] [Abstract][Full Text] [Related]
24. How we treat tumor lysis syndrome.
Muslimani A; Chisti MM; Wills S; Nadeau L; Zakalik D; Daw H; Huang J; Jaiyesimi I
Oncology (Williston Park); 2011 Apr; 25(4):369-75. PubMed ID: 21618960
[TBL] [Abstract][Full Text] [Related]
25. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review.
Howard SC; Trifilio S; Gregory TK; Baxter N; McBride A
Ann Hematol; 2016 Mar; 95(4):563-73. PubMed ID: 26758269
[TBL] [Abstract][Full Text] [Related]
26. [Acute tumor lysis syndrome: update on therapy].
Jabbour E; Ribrag V
Rev Med Interne; 2005 Jan; 26(1):27-32. PubMed ID: 15639323
[TBL] [Abstract][Full Text] [Related]
27. Tumor lysis syndrome in children with non-Hodgkin lymphoma.
Alavi S; Arzanian MT; Abbasian MR; Ashena Z
Pediatr Hematol Oncol; 2006; 23(1):65-70. PubMed ID: 16326415
[TBL] [Abstract][Full Text] [Related]
28. Ixazomib-associated tumor lysis syndrome in multiple myeloma: A case report.
Jin F; Yang M; Chen Y; Jiang L; Liu L
Medicine (Baltimore); 2020 Nov; 99(45):e22632. PubMed ID: 33157919
[TBL] [Abstract][Full Text] [Related]
29. Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature.
Chen SW; Hwang WS; Tsao CJ; Liu HS; Huang GC
J Clin Pharm Ther; 2005 Dec; 30(6):623-5. PubMed ID: 16336296
[TBL] [Abstract][Full Text] [Related]
30. Tumor lysis syndrome: risk factors, diagnosis, and management.
Burns RA; Topoz I; Reynolds SL
Pediatr Emerg Care; 2014 Aug; 30(8):571-6; quiz 577-9. PubMed ID: 25098804
[TBL] [Abstract][Full Text] [Related]
31. [Tumor lysis syndrome].
Hagino T
Gan To Kagaku Ryoho; 2010 Jun; 37(6):984-8. PubMed ID: 20567098
[TBL] [Abstract][Full Text] [Related]
32. Acute kidney injury in bortezomib-treated patients with multiple myeloma.
Song SM; Jeon J; Jang HR; Kim K; Huh W; Kim YG; Lee JE
Nephrol Dial Transplant; 2023 Aug; 38(9):2077-2085. PubMed ID: 36662030
[TBL] [Abstract][Full Text] [Related]
33. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
[TBL] [Abstract][Full Text] [Related]
34. Tumour lysis syndrome complicating high-dose treatment in patients with multiple myeloma.
Fassas AB; Desikan KR; Siegel D; Golper TA; Munshi NC; Barlogie B; Tricot G
Br J Haematol; 1999 Jun; 105(4):938-41. PubMed ID: 10554803
[TBL] [Abstract][Full Text] [Related]
35. Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.
Dimopoulos MA; Roussou M; Gavriatopoulou M; Zagouri F; Migkou M; Matsouka C; Barbarousi D; Christoulas D; Primenou E; Grapsa I; Terpos E; Kastritis E
Clin Lymphoma Myeloma; 2009 Aug; 9(4):302-6. PubMed ID: 19717380
[TBL] [Abstract][Full Text] [Related]
36. [Metabolic disorders in the treatment of malignant hematologic diseases--the acute tumor lysis syndrome].
Nielsen SH; Hasselbalch HC; Birgens HS
Ugeskr Laeger; 1991 Oct; 153(42):2952-3. PubMed ID: 1949322
[TBL] [Abstract][Full Text] [Related]
37. Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency.
Criscuolo M; Fianchi L; Dragonetti G; Pagano L
Expert Rev Hematol; 2016; 9(2):197-208. PubMed ID: 26629730
[TBL] [Abstract][Full Text] [Related]
38. Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.
Chim CS
Cancer Chemother Pharmacol; 2008 Jun; 62(1):181-2. PubMed ID: 17846773
[No Abstract] [Full Text] [Related]
39. [Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report].
He H; Li C; Han M
Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):310-2. PubMed ID: 11721390
[TBL] [Abstract][Full Text] [Related]
40. Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
Huston A; Brown J; Roodman GD
Exp Hematol; 2006 Dec; 34(12):1616. PubMed ID: 17157156
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
